Bangladesh has been conducting annual serological surveillance for HIV and syphilis since 1998 among most at-risk populations including sex workers, males having sex with males, injecting drug users (IDUs) and heroin smokers. During the seventh round conducted between January and June 2006, 10,368 people were sampled and the overall HIV prevalence was 0.9%. The highest HIV rate was recorded in male IDUs from the capital city Dhaka (7%), and the rates have risen significantly over the rounds (P < 0.001). In Dhaka, most of the HIV-positive IDUs (10.5%) were localized in one neighbourhood, while in the remaining neighbourhoods 1% were positive (P < 0.001). In all other groups, HIV prevalence was P < 0.001). Bangladesh has to act urgently to prevent escalation of the epidemic.
AlamMS, SarkerMS, MahmudAM.Low HIV infection rates among tuberculosis patients in Dhaka, Bangladesh. Int J STD AIDS2005; 16: 86–8.
2.
AzimT, IslamMN, BogaertsJ.Prevalence of HIV and syphilis among high-risk groups in Bangladesh. AIDS2000; 14: 210–1.
3.
BogaertsJ, AhmedJ, AkhterN.Sexually transmitted infections among married women in Dhaka, Bangladesh: unexpected high prevalence of herpes simplex type 2 infection. Sex Transm Infect2001; 77: 114–9.
4.
HawkesS, MorisonL, ChakrabortyJ.Reproductive tract infections: prevalence and risk factors in rural Bangladesh. Bull World Health Organ2002; 80: 180–8.
5.
UNAIDS/WHO.Guidelines for Second Generation HIV Surveillance.Geneva: UNAIDS/WHO, 2000
6.
Government of Bangladesh.National HIV Serological and Behavioural Surveillance, 2003-2004, Bangladesh. Fifth round technical report. Dhaka: National AIDS/STD Programme, Directorate General of Health Services, Ministry of Health and Family Welfare, Government of Bangladesh, 2006
7.
Government of Bangladesh.National HIV Serological Surveillance, 2004-2005, Bangladesh. Sixth Round Technical Report. Dhaka: National AIDS/STD Programme, Directorate General of Health Services, Ministry of Health and Family Welfare, Government of Bangladesh, 2005
8.
GibneyL, SaquibN, MetzgerJ, ChoudhuryP, SiddiquiM, HassanM.Human immunodeficiency virus, hepatitis B, C and D in Bangladesh's trucking industry: prevalence and risk factors. Int J Epidemiol2001; 30: 878–84.
9.
AzimT, ChowdhuryEI, RezaM.Vulnerability to HIV infection among sex worker and non-sex worker female injecting drug users in Dhaka, Bangladesh: evidence from the baseline survey of a cohort study. Harm Redn J2006; 3: 33
10.
SarkarK, BalB, MukherjeeR, NiyogiSK, SahaMK, BhattacharyaSK.Cross border HIV epidemic among injecting drug users of Himalayan West Bangal. Eur J Epidemiol2005; 20: 373–5.
11.
BeckerML, RameshBM, WashingtonRG, HalliS, BlanchardJF, MosesS.Prevalence and determinants of HIV infection in South India: a heterogeneous, rural epidemic. AIDS2007; 21: 739–47.
12.
BeyrerC, RazakMH, LabriqueA, BrookmeyerR.Assessing the magnitude of the HIV/AIDS epidemic in Burma. J Acquir Immune Defic Syndr2003; 32: 311–7.
13.
Government of Bangladesh.HIV in Bangladesh: Is Time Running Out?Dhaka: National AIDS/STD Program, Directorate General of Health Services, Ministry of Health and Family Welfare, Government of Bangladesh, 2003
14.
Bangladesh Bureau of Statistics.Demographics of Bangladesh, 2001; 5[http://www.bbs.gov.bd]
15.
WilliamsBG, Lloyd-SmithJO, GouwsE.The potential impact of male circumcision on HIV in sub-Saharan Africa. PLoS Med2006; 3: e262.
16.
UNAIDS, Best Practice Collection.High Coverage Sites. HIV Prevention Among Injecting Drug Users in Transitional and Developing Countries: Case Studies.Geneva: UNAIDS, 2006
17.
UNAIDS.Female Sex Worker HIV Prevention Projects: Lessons Learnt from Papua New Guinea, India and Bangladesh.Geneva: UNAIDS, 2000
18.
FossA, WattCJ, VickermanP.Could the CARE-SHAKTI intervention for injecting drug users be maintaining the low HIV prevalence in Dhaka, Bangladesh?Addiction2007; 102: 114–25.
19.
AzimT, HusseinN, KellyR.Effectiveness of harm reduction programmes for injecting drug users in Dhaka city. Harm Reduct J2005; 2: 22
20.
PandaS, KumarMS, LokabiramanS.Risk factors for HIV infection in injection drug users and evidence for onward transmission of HIV to their sexual partners in Chennai, India. J Acquir Immune Defic Syndr2005; 39: 9–15.
21.
SarkarS, DasN, PandaS.Rapid spread of HIV among injecting drug users in north-eastern states of India. Bull Narc1993; 45: 91–105.
22.
ShahSA, AltafA, MujeebSA, MemonA.An outbreak of HIV infection among injection drug users in a small town in Pakistan: potential for national implications. Int J STD AIDS2004; 15: 209
23.
OelrichsRB, ShresthaIL, AndersonDA, DeaconNJ.The explosive human immunodeficiency virus type 1 epidemic among injecting drug users of Kathmandu, Nepal, is caused by a subtype C virus of restricted genetic diversity. J Virol2000; 74: 1149–57.
24.
PandaS, ChatterjeeA, BhattacharyaSK.Transmission of HIV from injecting drug users to their wives in India. Int J STD AIDS2000; 11: 468–73.
25.
SaidelTJ, Des JarlaisDC, PeerapatanapokinW, DorabjeeJ, SinghS, BrownT.Potential impact of HIV among IDUs on heterosexual transmission in Asian settings: scenarios from the Asian epidemic model. Int J Drug Policy2003; 14: 63–74.
26.
GibsonDR, BrandR, AndersonK, KahnJG, PeralesD, GuydishJ.Two- to sixfold decreased odds of HIV risk behavior associated with use of syringe exchange. J Acquir Immune Defic Syndr2002; 31: 237–42.
27.
VlahovD, Des JarlaisDC, GoosbyE.Needle exchange programs for the prevention of human immunodeficiency virus infection: epidemiology and policy. Am J Epidemiol2001; 154: S70–S7.
